Translation and clinical validation of the Hungarian version of the Acute Cystitis Symptom Score (ACSS) questionnaire

2016 ◽  
Vol 15 (11) ◽  
pp. e1442
Author(s):  
A. Magyar ◽  
J. Alidjanov ◽  
K. Naber ◽  
F. Wagenlehner ◽  
B. Köves ◽  
...  
Keyword(s):  
Symptom Score ◽  
Clinical Validation ◽  
Acute Cystitis ◽  
Hungarian Version

scholarly journals Acute Cystitis Symptom Score (ACSS): Clinical Validation of the Italian Version

Antibiotics ◽  
2020 ◽  
Vol 9 (3) ◽  
pp. 104 ◽  
Author(s):  
Tommaso Di Vico ◽  
Riccardo Morganti ◽  
Tommaso Cai ◽  
Kurt G. Naber ◽  
Florian M.E. Wagenlehner ◽  
...  
Keyword(s):  
Symptom Score ◽  
Control Group ◽  
Clinical Validation ◽  
Italian Version ◽  
Roc Curve Analysis ◽  
Linguistic Validation ◽  
Acute Cystitis ◽  
Patient Reported ◽  
Self Reporting Questionnaire

Acute Cystitis Symptom Score (ACSS) is an 18-item self-reporting questionnaire for clinical diagnosis and follow-up of acute uncomplicated cystitis (AUC) in women. The ACSS, originally developed in Uzbek and Russian languages, is now available in several languages. The purpose of the study was to validate the ACSS questionnaire in the Italian language. Linguistic validation was carried out according to Linguistic Validation Manual for Patient-Reported Outcomes Instruments guidelines. Clinical validation was carried out by enrolling one hundred Italian-speaking women. All women were asked to fill in the ACSS questionnaire during their medical visit. Fifty-four women, median age 36 (Inter Quartile Range 28–49), were diagnosed with AUC, while 46 women, median age 38 (IQR 29–45), were enrolled as the control group attending the hospital’s fertility center for couples. The most frequently isolated pathogen in AUC was Escherichia coli (40; 74.0%) followed by Enterococcus faecalis (7; 13.0%) and Staphylococcus saprophyticus (3; 5.6%). Receiver operating characteristic (ROC) curve analysis performed at the first diagnostic visit on a typical symptoms domain cut-off score of 6 revealed a sensitivity of 92.5% and specificity of 97.8%. The Italian version of the ACSS has proved to be a reliable tool with a high accuracy in diagnosis and follow-up in women with AUC. The ACSS may also be useful for clinical and epidemiological studies.

Linguistic and clinical validation of the Greek Acute Cystitis Symptom Score questionnaire

2021 ◽  
Vol 79 ◽  
pp. S212
Author(s):  
K. Stamatiou ◽  
E. Samara ◽  
J.F. Alidjanov ◽  
K.G. Naber ◽  
A.M.E. Pilatz ◽  
...  
Keyword(s):  
Symptom Score ◽  
Clinical Validation ◽  
Acute Cystitis

scholarly journals Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS). Part II

2021 ◽  
Author(s):  
Konstantinos Stamatiou ◽  
Evangelia Samara ◽  
Jakhongir F. Alidjanov ◽  
Adrian M. E. Pilatz ◽  
Kurt G. Naber ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Clinical Outcome ◽  
Symptom Score ◽  
Patient Reported Outcome ◽  
Clinical Validation ◽  
Acute Cystitis ◽  
Significant Difference ◽  
Patient Reported ◽  
Self Reporting Questionnaire

The Acute Cystitis Symptom Score (ACSS) is a patient self-reporting questionnaire for the clinical diagnosis and patient-reported outcome (PRO) in women with acute uncomplicated cystitis (AC). The aim of the current study (part II) was the clinical validation of the Greek ACSS questionnaire. After linguistic validation according to internationally accepted guidelines and cognitive assessment (part I), the clinical validation was performed after ethical approval by using the Greek ACSS study version in 92 evaluable female participants including 53 patients with symptoms suspicious of AC and 39 controls. The clinical outcome using the ACSS questionnaire at different time points after the start of treatment was demonstrated as well. The age (mean±SD) of the 53 patients (44.7±17.0) and 39 controls (49.3±15.9) and their additional conditions at baseline visits, such as menstruation, premenstrual syndrome, pregnancy, menopause, diabetes mellitus, were comparable. There was, however, a significant difference (p<0.001) between patients and controls at baseline visit regarding sum score of the ACSS domains, such as typical symptoms and quality of life. The clinical outcome of up to 7 days showed a fast reduction of the symptom scores and improvement of quality of life. The optimal thresholds for the patient-reported outcome of successful therapy could be established. The linguistically and clinically validated Greek ACSS questionnaire can now be used for clinical or epidemiological studies and also for patient’s self-diagnosis of AC and as a PRO measure tool.

scholarly journals Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

Antibiotics ◽  
2021 ◽  
Vol 10 (10) ◽  
pp. 1253
Author(s):  
Konstantinos Stamatiou ◽  
Evangelia Samara ◽  
Jakhongir F. Alidjanov ◽  
Adrian M. E. Pilatz ◽  
Kurt G. Naber ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Clinical Outcome ◽  
Symptom Score ◽  
Patient Reported Outcome ◽  
Clinical Validation ◽  
Acute Cystitis ◽  
Significant Difference ◽  
Patient Reported ◽  
Self Reporting Questionnaire

The Acute Cystitis Symptom Score (ACSS) is a patient self-reporting questionnaire for the clinical diagnosis and patient-reported outcome (PRO) in women with acute uncomplicated cystitis (AC). The aim of the current study (part II) is the clinical validation of the Greek ACSS questionnaire. After linguistic validation according to internationally accepted guidelines and cognitive assessment (part I), the clinical validation was performed by using the Greek ACSS study version in 92 evaluable female participants including 53 patients with symptoms suspicious of AC and 39 controls. The clinical outcome using the ACSS questionnaire at different points in time after the start of treatment was demonstrated as well. The age (mean ± SD) of the 53 patients (44.7 ± 17.0 years) and 39 controls (49.3 ± 15.9 years) and their additional conditions at baseline visits, such as menstruation, premenstrual syndrome, pregnancy, menopause, diabetes mellitus, were comparable. There was, however, a significant difference (p < 0.001) between patients and controls at baseline visit regarding sum score of the ACSS domains, such as typical symptoms and quality of life. The clinical outcome of up to 7 days showed a fast reduction of the symptom scores and improvement of quality of life. The optimal thresholds for the patient-reported outcome of successful therapy could be established. The linguistically and clinically validated Greek ACSS questionnaire can now be used for clinical or epidemiological studies and also for patients’ self-diagnosis of AC and as a PRO measure tool.

scholarly journals Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part II. Patient-Reported Outcome Assessment

Antibiotics ◽  
2018 ◽  
Vol 7 (2) ◽  
pp. 43 ◽  
Author(s):  
Jakhongir Alidjanov ◽  
Kurt Naber ◽  
Ulugbek Abdufattaev ◽  
Adrian Pilatz ◽  
Florian Wagenlehner
Keyword(s):  
Outcome Assessment ◽  
Symptom Score ◽  
Patient Reported Outcome ◽  
Acute Cystitis ◽  
Patient Reported ◽  
Self Reporting Questionnaire

scholarly journals Neuer Fragebogen zur deutschen Validierung des „Acute Cystitis Symptom Score“

Der Urologe ◽  
2017 ◽  
Vol 56 (3) ◽  
pp. 364-366 ◽  
Author(s):  
J. F. Alidjanov ◽  
A. Pilatz ◽  
U. A. Abdufattaev ◽  
J. Wiltink ◽  
W. Weidner ◽  
...  
Keyword(s):  
Symptom Score ◽  
Acute Cystitis
Sign in / Sign up

Export Citation Format

Share Document